VONENTIAL Trademark

Trademark Overview

On Thursday, October 18, 2018, a trademark application was filed for VONENTIAL with the United States Patent and Trademark Office. The USPTO has given the VONENTIAL trademark a serial number of 88160468. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 13, 2022. This trademark is owned by Agouron Pharmaceuticals, LLC. The VONENTIAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
vonential

General Information

Serial Number88160468
Word MarkVONENTIAL
Filing DateThursday, October 18, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 13, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgouron Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameAgouron Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, June 13, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 13, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 22, 2021SOU EXTENSION 5 GRANTED
Thursday, October 14, 2021SOU EXTENSION 5 FILED
Friday, October 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 14, 2021TEAS EXTENSION RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021SOU EXTENSION 4 GRANTED
Wednesday, April 7, 2021SOU EXTENSION 4 FILED
Wednesday, April 7, 2021TEAS EXTENSION RECEIVED
Friday, October 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2020SOU EXTENSION 3 GRANTED
Wednesday, September 30, 2020SOU EXTENSION 3 FILED
Wednesday, September 30, 2020TEAS EXTENSION RECEIVED
Saturday, April 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 2, 2020SOU EXTENSION 2 GRANTED
Thursday, April 2, 2020SOU EXTENSION 2 FILED
Thursday, April 2, 2020TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2019SOU EXTENSION 1 GRANTED
Thursday, October 10, 2019SOU EXTENSION 1 FILED
Thursday, October 10, 2019TEAS EXTENSION RECEIVED
Tuesday, May 7, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 28, 2019ASSIGNED TO EXAMINER
Wednesday, October 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 22, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

vonential preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological